Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box | European Respiratory Society
Frontiers | Single Inhaler LABA/LAMA for COPD
Principal differences between inhaler devices used to deliver LAMA/LABA... | Download Scientific Diagram
In Depth | Anoro Ellipta: first LABA/LAMA combination inhaler for COPD
The role of LABA/LAMA and add-on therapies in the management of... | Download Scientific Diagram
COPD Medications: Types and Benefits - COPD info
Key studies on major LABA/LAMA fixed-dose combinations in patients with... | Download Scientific Diagram
Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study | Archivos de Bronconeumología
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
Effect of adding a LABA to a LAMA on FEV 1 in patients with COPD | Download Scientific Diagram
Follow Up Treatment | Stiolto® Respimat® Inhalation Spray | HCP
Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease ( COPD): Boon or Bane? | American Board of Family Medicine
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine
LAMA/LABA Fixed-dose Combo May Be Superior for COPD Therapy | RT
Figure 1 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
Navigating New Treatment Options for COPD | Consultant360
BPCO: rischio di eventi cardiovascolari e terapia combinata – HarDoctor News, il Blog di Carlo Cottone
Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients? | Respiratory Research | Full Text
COPD Inhalers - Easy to Use Reference Tool - CommPharm Consulting
LAMA/LABA therapy reduced risk for COPD exacerbation, pneumonia hospitalization
Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database | Advances in Therapy
A new alphabet for COPD care | European Respiratory Society
Chronic obstructive pulmonary disease (COPD) - Management Approach | BMJ Best Practice
Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework | Respiratory Research | Full Text
